Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Experiment Videos

Radioactive iodine therapy in Graves' hyperthyroidism.

R Sankar1, G Sripathy

  • 1Institute of Nuclear Medicine and Allied Sciences, Lucknow Road, Timarpur, Delhi 110054, India. natram@mantraonline.com

The National Medical Journal of India
|February 24, 2001
PubMed
Summary
This summary is machine-generated.

Related Concept Videos

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

Improving the efficiency of induction motor drive by flux and torque control: A hybrid LSE-RERNN approach.

ISA transactions·2024
Same author

Benthic foraminifera as an environmental proxy for pollutants along the coast of Chennai, India.

Chemosphere·2022
Same author

Large magnetoresistance and quantum oscillations in Sn<sub>0.05</sub>Pb<sub>0.95</sub>Te.

Journal of physics. Condensed matter : an Institute of Physics journal·2021
Same author

Contrasting the Surface Phonon Dispersion of Pb_{0.7}Sn_{0.3}Se in Its Topologically Trivial and Nontrivial Phases.

Physical review letters·2019
Same author

Gd<sub>2</sub>Te<sub>3</sub>: an antiferromagnetic semimetal.

Journal of physics. Condensed matter : an Institute of Physics journal·2019
Same author

Long-term effects of allergen-specific subcutaneous immunotherapy for house dust mite induced allergic rhinitis.

The Journal of laryngology and otology·2018

Radioiodine therapy is a safe and effective treatment for Graves' disease, a common cause of hyperthyroidism. This definitive treatment, often using a fixed dose, eliminates hyperthyroidism and leads to physician-controlled hypothyroidism.

Area of Science:

  • Endocrinology
  • Nuclear Medicine

Background:

  • Graves' disease is a prevalent autoimmune disorder causing hyperthyroidism.
  • Current treatments include antithyroid drugs, radioiodine, and surgery.

Purpose of the Study:

  • To review the efficacy and safety of radioiodine therapy for Graves' disease.
  • To highlight radioiodine as a preferred treatment option for most adult patients.

Main Methods:

  • Review of existing evidence on radioiodine therapy for Graves' hyperthyroidism.
  • Discussion of fixed dose regimens and thyroablative strategies.
  • Consideration of contraindications and potential side effects.

Main Results:

  • Radioiodine therapy is effective for most hyperthyroid patients, especially those beyond adolescence.

Related Experiment Videos

  • Fixed dose regimens are gaining acceptance for predictable outcomes.
  • Hypothyroidism is an expected, physician-controlled outcome.
  • Exacerbation of ophthalmopathy can be mitigated with corticosteroids.
  • No adverse effects on offspring or increased risk of cancer, leukemia, or infertility observed.

    • Conclusions:

    • Radioiodine therapy is a safe, definitive, and cost-effective treatment for Graves' hyperthyroidism.
    • It offers predictable elimination of hyperthyroidism with manageable hypothyroidism.
    • Contraindications include pregnancy and breastfeeding.